- Home
- FGNX vs TELA Comparison
FGNX vs TELA Comparison
Compare FGNX & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FGNX | TELA |
|---|---|---|
| Founded | 1932 | 2012 |
| Country | United States | United States |
| Employees | 15 | N/A |
| Industry | Property-Casualty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.5M | 37.5M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | FGNX | TELA |
|---|---|---|
| Price | $6.59 | $0.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $35.00 | $2.00 |
| AVG Volume (30 Days) | 74.6K | ★ 199.9K |
| Earning Date | 05-19-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 37.59 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $80,275,000.00 |
| Revenue This Year | $650.31 | $10.23 |
| Revenue Next Year | N/A | $14.26 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 15.84 |
| 52 Week Low | $1.59 | $0.50 |
| 52 Week High | $18.42 | $2.19 |
Technical Indicators
Market Signals| Indicator | FGNX | TELA |
|---|---|---|
| Relative Strength Index (RSI) | 59.27 | 45.14 |
| Support Level | $6.52 | $0.52 |
| Resistance Level | $7.83 | $0.91 |
| Average True Range (ATR) | 0.52 | 0.10 |
| MACD | 0.16 | 0.01 |
| Stochastic Oscillator | 94.37 | 42.02 |
Price Performance
Historical ComparisonAbout FGNX Fundamental Global Inc.
FG Nexus Inc is a capital markets platform focused on long-term Ethereum (ETH) accumulation and on-chain yield generation. The company provides institutional investors with secure, regulated access to ETH as a productive reserve asset, generating native staking yield while underpinning stablecoins, tokenized assets, and AI-driven applications.
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.